Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis

BACKGROUND: Recently, several newer antiplatelet treatment strategies have been used in patients with coronary artery disease (CAD). Apart from the dual antiplatelet therapy (DAPT) consisting of aspirin and clopidogrel, double dose clopidogrel (DDC), triple antiplatelet therapy (TAPT) consisting of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuo, Xiaojun, Zhuo, Bi, Ouyang, Shenyu, Niu, Pei, Xiao, Mou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122215/
https://www.ncbi.nlm.nih.gov/pubmed/30176938
http://dx.doi.org/10.1186/s40360-018-0247-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122215/
https://www.ncbi.nlm.nih.gov/pubmed/30176938
http://dx.doi.org/10.1186/s40360-018-0247-9

Ejemplares similares